维普中文期刊产品整合服务
117篇 您的检索式:作者名="MATTHEW P H"
    题名 作者 年代 出处 被引量
1Metabolic and hepatic effects of liraglutide,obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis显示文摘AIM To evaluate the pharmacodynamics of compounds in clinical development for nonalcoholic steatohepatitis(NASH) in obese mouse models of biopsy-confirmedNASH.METHODS Male wild-type C57 BL/6 J mice(DIO-NASH) and Lep^(ob/ob)(ob/ob-NASH) mice were fed a diet high in trans-fat(40%), fructose(20%) and cholesterol(2%) for 30 and 21 wk, respectively. Prior to treatment, all mice underwent liver biopsy for confirmation and stratification of liver steatosis and fibrosis, using the nonalcoholic fatty liver disease activity score(NAS) and fibrosis staging system. The mice were kept on the diet and received vehicle, liraglutide(0.2 mg/kg, SC, BID), obeticholic acid(OCA, 30 mg/kg PO, QD), or elafibranor(30 mg/kg PO, QD) for eight weeks. Within-subject comparisons were performed on changes in steatosis, inflammation, ballooning degeneration, and fibrosis scores. In addition, compound effects were evaluated by quantitative liver histology, including percent fractional area of liver fat, galectin-3, and collagen 1 a1.RESULTS Liraglutide and elafibranor, but not OCA, reduced body weight in both models. Liraglutide improved steatosis scores in DIO-NASH mice only. Elafibranor and OCA reduced histopathological scores of hepatic steatosis and inflammation in both models, but only elafibranor reduced fibrosis severity. Liraglutide and OCA reduced total liver fat, collagen 1 a1, and galectin-3 content, driven by significant reductions in liver weight. The individual drug effects on NASH histological endpoints were supported by global gene expression(RNA sequencing) and liver lipid biochemistry.CONCLUSION DIO-NASH and ob/ob-NASH mouse models show distinct treatment effects of liraglutide, OCA, and elafibranor, being in general agreement with corresponding findings in clinical trials for NASH. The present data therefore further supports the clinical translatability and utility of DIO-NASH and ob/ob-NASH mouse models of NASH for probing the therapeutic efficacy of compounds in preclinical drug development for NASH.Kirstine S Tolbol Maria NB Kristiansen Henrik H Hansen Sanne S Veidal Kristoffer TG Rigbolt Matthew P Gillum Jacob Jelsing Niels Vrang Michael Feigh 2018World Journal of Gastroenterology2018,24,2:5
2Tumorigenesissuppressor Pdcd4 dow n-regulates mitogen-activated pro-tein kinase 1 expression to suppress colon carcinoma cellinvasion显示文摘Yang H S Matthews C P Clair T 2006Mol Cell Biol2006,26,4:1
3Evaluation of the biocompatibility of a chitosan scaffold in mice显示文摘vander Vord P J Matthew H W DeSilva S P et aI 2002Biomed Mater Res2002,59,3:1
4Adaptation of HIV-1to human leukocyte antigen class I显示文摘Kawashima Y Pfafferott K Frater J Matthews P Payne R Addo M Gatanaga H Fujiwara M Hachiya A Koizumi H Kuse N Oka S Duda A Prendergast A Crawford H Leslie A Brumme Z Brumme C Allen T Brander C Kaslow R Tang J Hunter E Allen S Mulenga J Branch S Roach T John M Mallal S Ogwu A Shapiro R Prado J G Fidler S Weber J Pybus O G Klenerman P Ndung'u T Phillips R Heckerman D Harrigan P R Walker B D Takiguchi M Goulder P 2009Nature2009,458,7238:1
5Comparative Life- cycleAir Emissions of Coal,Domestic Natural Gas,LNG,and SNG forElectricity Generation 显示文摘Jaramillo P Griffin W M Matthews H S 2007Environmental Science & Technology2007,41,17:1
6Variable structure control of nonlinear multivariable systems: a tutorial 显示文摘de Carlo R A Zak S H Matthews G P 1988Proceedings of the IEEE1988,76,3:1
7Morphology and the Internal Structure of Words 显示文摘DEVLIN J T JAMISON H L MATTHEWS P M 2004Pro- ceedings of the National Academy of Sciences2004,101,14:1
8Evaluation ofthe biocompatibility of a chitosan scaffold in mice 显示文摘VandeYord P J Matthew H W DeSilva S P 2002BiomedMater Res2002,59,3:1
9The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy显示文摘Stephan Harbarth Stanley L Pestotnik James F Lloyd John P Burke Matthew H Samore 2001The American Journal of Medicine2001,,:1
10Ultrasonically assisted synthesis and degradation of poly ( dimethyl siloxane) 显示文摘Gareth J P Matthew P H Emma N K W 1996Polymer1996,37,12:1
11显示文摘VandeVord P J Matthew H W DeSilva S P 2002Journal of Biomedical Materials Research2002,59,3:1
12Changes in Neutrophil Surface Receptor expression,Degranulation,and Respiratory Burst Activity Following Moderate and High Intensity Exercise显示文摘Jonathan P Gary W Matthew H 0,,02:1
13Laser capture microdissection (LCM) and comparative microarray expression analysis of syncytial cells isolated from incompatible and compatible soybean (Glycine max) roots infected by soybean cyst nematode (Heterodera glycines)显示文摘Klink V P Overall C C Alkharouf N MacDonald M H Matthews B F 0,,06:1
14Experimental studies in the LENS supersonic and hypersonic tunnels for hypervelocity vehicle performance and code validation 显示文摘Michael S H Timothy P W Matthew M 2008AIAA2008,2505,:1
15Variable structure control of nonlinear multivariable systems: A tutorial 显示文摘DeCarlo R A Zak S H Matthews G P 1988IEEE Proceeding1988,76,:1
16Nucleotide sequence and analysis and comparison of the structural genes for Shiga-like toxin i and Shiga-like toxin Ⅱ encoded by bacteriophages from Escherichia coli 933显示文摘MATTHEW P J ROGER J H ALISON D O 1987FEMS Microbiology Letters1987,44,10:1
17Investigating employee perceptions of a framework of safety culture maturity显示文摘MATTHEW L DIANNE P PATRICK H 2006Safety Science2006,44,:1
18Inflammation-associated lysophospholipids as ligands for CD1D-restricted T cells in human cancer显示文摘Chang DH Deng H Matthews P 2008Blood2008,112,4:1
19Evaluation of the biocompatibility of a chitosan scaffold in mice显示文摘VandeVord P J Matthew H W T DeSilva S P 2002J Biomed Mater Res2002,59,3:1
20Prediction of mammalian microRNA targets显示文摘Lewis B P Shih I H Matthew W J 2003Cell2003,115,:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费